Cyclosporine A in the treatment of a patient with immune thrombocytopenia accompanied by myelodysplastic syndrome and nephrotic syndrome

Acta Haematologica

Volumn 110, Issue 1, 2003, Pages 36-40

  Park, Soo Jeong ^a   Han, Chi Wha ^a   Lee, Je Hoon ^a   Eom, Hyeon Seok ^a   Lee, Seung Hun ^a   Jeong, Dae Chul ^a   Lim, Ji Hyang ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cyclosporine A; Myelodysplastic syndrome; Nephrotic syndrome; Thrombocytopenia

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOGLOBULIN; PREDNISOLONE; THROMBOCYTE ANTIBODY;

AGED; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; FLOW CYTOMETRY; HUMAN; LABORATORY TEST; LEG EDEMA; MYELODYSPLASTIC SYNDROME; NEPHRITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

AGED; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYELODYSPLASTIC SYNDROMES; NEPHROTIC SYNDROME; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REMISSION INDUCTION;

EID: 0141788388     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072413     Document Type: Article

References (22)

1. Mhawech P, Saleem A: Myelodysplastic syndrome: Review of the cytogenetic and molecular data. Crit Rev Oncol Hematol 2001;40/3:229-238.
2. Seipelt G, Ottmann OG, Hoelzer D: Cytokine therapy for myelodysplastic syndrome. Curr Opin Hematol 2000;7/3:156-160.
3. Legare RD, Gilliland DG: Myelodysplastic syndrome. Curr Opin Hematol 1995;2/4:283-292.
4. Forman SJ: Myelodysplastic syndrome. Curr Opin Hematol 1996;3/4:297-302.
5. Nigam S, Rani S, Singh T, Gupta S, Rakheja D, Gaiha M: Clinical, hematological and histomorphological profile of myelodysplastic syndrome. J Assoc Physicians India 2001;49:430-434.
6. Imoto S, Hayashi Y, Matsui T, Murayama T, Iwata N, Matsuoka H, Nagata A, Itoh H, Chihara K: Refractory thrombocytopenia with chromosome 11q23 abnormality. Ann Hematol 1996;73/2:99-102.
7. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W: Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: Response to immunosuppressive therapy. Br J Haematol 1995;91:403-408.
8. Funato K, Kuriyama Y, Uchida Y, Suzuki A, Miyazawa K, Ohyashiki K: Myelodysplastic syndrome accompanied by Addison's disease and multiple autoimmune phenomena: Steroid therapy resolved cytopenias and all immune disorders. Intern Med 2001;40:1041-1044.
9. Olave MT, Iturbe T, Fuertes MA, Palomera L: Autoimmune thrombocytopenia in the clinical context of myelodysplasia with chromosome 7 deletion, intestinal tuberculosis, and chronic hepatitis caused by hepatitis C virus. Sangre (Barc) 1999;44:495-496.
10. Hebbar M, Kaplan C, Caulier MT, Wattel E, Morel P, Wetterwald M, Bauters F, Fenaux P: Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy. Br J Haematol 1996;94/1:112-115.
11. Roman A, Cabello A, Soto C, Olavarria E, Sanchez Fayos J: Myelodysplastic syndrome mimicking sequentially an idiopathic thrombocytopenia purpura and an aplastic pancytopenia. Sangre (Barc) 1994;39/3:226.
12. Menke DM, Colon-Otero G, Cockerill KJ, Jenkins RB, Noel P, Pierre RV: Refractory thrombocytopenia. A myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol 1992;98:502-510.
13. Emilia G, Morselli M, Luppi M, Longo G, Marasca R, Gandini G, Ferrara L, D'Apollo N, Potenza L, Bertesi M, Torelli G: Long-term salvage therapy with cyclosporine A in refractory idiopathic thrombocytopenic purpura. Blood 2002;99:1482-1485.
14. Kappers-Klunne MC, van't Veer MB: Cyclosporin A for the treatment of patients with chronic idiopathic thrombocytopenic purpura refractory to corticosteroids or splenectomy. Br J Haematol 2001;114/1:121-125.
15. Moskowitz IP, Gaynon PS, Shahidi NT, Cripe TP: Low-dose cyclosporine A therapy in children with refractory immune thrombocytopenic purpura. J Pediatr Hematol Oncol 1999;21/1:77-79.
16. Gesundheit B, Cividalli G, Freeman A, Yatziv S, Koren G, Baruchel S: Cyclosporine A in the treatment of refractory immune thrombocytopenia purpura in children. Eur J Haematol 2001;66:347-351.
17. Shirota T, Yamamoto H, Fujimoto H, Harada Y, Okada K, Uchida H, Roppongi H, Hayashi T: Cyclic thrombocytopenia in a patient treated with cyclosporine for refractory idiopathic thrombocytopenic purpura. Am J Hematol 1997;56/4:272-276.
18. Jonasova A, Neuwirtova R, Cermak J, Vozobulova V, Mocikova K, Siskova M, Hochova I: Cyclosporine A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol 1998;100:304-309.
19. Catalano L, Selleri C, Califano C, Luciano L, Volpicelli M, Rocco S, Varriale G, Ricci P, Rotoli B: Prolonged response to cyclosporine-A in hypoplastic refractory anemia and correlation with in vitro studies. Haematologica 2000;85/2:133-138.
20. Smith MA, Smith JG: The occurrence subtype and significance of haemopoietic inhibitory T cells (HIT cells) in myelodysplasia: An in vitro study. Leuk Res 1991;15:597-601.
21. Sugawara T, Endo K, Shishido T, Sato A, Kameoka J, Fukuhara O, Yoshinaga K, Miura A: T-cell mediated inhibition of erythropoiesis in myelodysplastic syndromes. Am J Hematol 1992;41:304-305.
22. Selleri C, Maciejewski JP, Catalano L, Ricci P, Andretta C, Luciano L, Rotoli B: Effects of cyclosporine on hematopoietic and immune functions in patients with hypoplastic myelodysplasia: In vitro and in vivo studies. Cancer 2002;95:1911-1922.